github link
Accession IconSRP106692

The immunosuppressive effect of the tick salivary protein, Salp15, is persistent and has long-term effects in a murine model of hematopoietic transplant

Organism Icon Mus musculus
Sample Icon 105 Downloadable Samples
Technology Badge IconIllumina HiScanSQ

Submitter Supplied Information

Description
Salp15, a salivary protein of Ixodes ticks, inhibits the activation of naïve CD4 T cells. Treatment with Salp15 results in immunomodulation in different murine models in which these cells participate. The fate of the CD4 T cells activated in the presence of the immunosuppressor or its long-term effects on these cells are however, unknown. We now show that Salp15 binding to CD4 is persistent and induces a long-lasting immunomodulatory effect. The activity of Salp15 results in sustained diminished antibody production against specific and unrelated antigens. Transcriptionally, the salivary protein provokes a sharp acute effect that includes known activation factors, such as Il2, Cd44, or Il2ra, and that fades over time. The long-term effects exerted by Salp15 do not involve the induction of either anergy traits nor increased populations of regulatory T cells. Similarly, the treatment with the immunomodulatory protein does not result in B cell anergy or the generation of myeloid suppressor cells. However, the immunomodulatory protein induces the increased expression of the ectoenzyme, CD73, in regulatory T cells. Our results suggest that the specific regulation of CD73, a known modulator of adenosine levels, by Salp15 results in long-term cross-antigenic immunomodulatory effects. Overall design: Genome-wide changes in gene Expression in mouse CD4 T cells activated with anti-CD3/CD28 in the presence of 25 ug/mL of the tick salivary protein, Salp15 or its inactive control (Salp15deltaP11) were generated by RNAseq.
PubMed ID
Total Samples
105
Submitter’s Institution
No associated institution

Samples

Show of 105 Total Samples
Filter
Add/Remove
Accession Code
Title
Age
Specimen part
Cell line
Treatment
Subject
Time
Processing Information
Additional Metadata
Purified splenic CD4 T cells number 3 activated with anti-CD3/CD28 + Salp15 day 4
8.000
blood
c57bl/6(h-2b)
salp15
purified splenic cd4 t cells, activated with anti-cd3/cd28 + salp15 day 4
day 4
NA
Purified splenic CD4 T cells number 1 unstimulated
8.000
blood
c57bl/6(h-2b)
non activated
purified splenic cd4 t cells, unstimulated
control
NA
Purified splenic CD4 T cells number 1 unstimulated
8.000
blood
c57bl/6(h-2b)
non activated
purified splenic cd4 t cells, unstimulated
control
NA
Purified splenic CD4 T cells number 2 unstimulated
8.000
blood
c57bl/6(h-2b)
non activated
purified splenic cd4 t cells, unstimulated
control
NA
Purified splenic CD4 T cells number 2 unstimulated
8.000
blood
c57bl/6(h-2b)
non activated
purified splenic cd4 t cells, unstimulated
control
NA
Purified splenic CD4 T cells number 2 unstimulated
8.000
blood
c57bl/6(h-2b)
non activated
purified splenic cd4 t cells, unstimulated
control
NA
Purified splenic CD4 T cells number 1 activated with anti-CD3/CD28 + Salp15deltaP11 day 2
8.000
blood
c57bl/6(h-2b)
salp15deltap11
purified splenic cd4 t cells, activated with anti-cd3/cd28 + salp15deltap11 day 2
day 2
NA
Purified splenic CD4 T cells number 1 activated with anti-CD3/CD28 + Salp15deltaP11 day 2
8.000
blood
c57bl/6(h-2b)
salp15deltap11
purified splenic cd4 t cells, activated with anti-cd3/cd28 + salp15deltap11 day 2
day 2
NA
Purified splenic CD4 T cells number 1 activated with anti-CD3/CD28 + Salp15deltaP11 day 2
8.000
blood
c57bl/6(h-2b)
salp15deltap11
purified splenic cd4 t cells, activated with anti-cd3/cd28 + salp15deltap11 day 2
day 2
NA
Purified splenic CD4 T cells number 2 activated with anti-CD3/CD28 + Salp15 day 4
8.000
blood
c57bl/6(h-2b)
salp15
purified splenic cd4 t cells, activated with anti-cd3/cd28 + salp15 day 4
day 4
NA
Loading...